Spinal actions of ω-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model

British Journal of Pharmacology

Volumn 170, Issue 2, 2013, Pages 245-254

  Jayamanne, A ^a   Jeong, H J ^a   Schroeder, C I ^b   Lewis, R J ^b   Christie, M J ^c   Vaughan, C W ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

calcium channel; conotoxin; neuropathic; pain; synaptic neurotransmission

Indexed keywords

OMEGA CONOTOXIN CVID; OMEGA CONOTOXIN MVIIA;

ADVERSE OUTCOME; ALLODYNIA; ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG SAFETY; IN VITRO STUDY; IN VIVO STUDY; MOTOR PERFORMANCE; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; ROTAROD TEST; SCORING SYSTEM; SPINAL CORD DORSAL HORN; SYNAPTIC INHIBITION; VISUAL SIDE EFFECT SCORE;

CALCIUM CHANNEL; CONOTOXIN; NEUROPATHIC; PAIN; SYNAPTIC NEUROTRANSMISSION;

ANALGESICS, NON-NARCOTIC; ANIMALS; CALCIUM CHANNEL BLOCKERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERALGESIA; MALE; NEURALGIA; OMEGA-CONOTOXINS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; ROTAROD PERFORMANCE TEST; SPINAL CORD; SYNAPTIC TRANSMISSION;

EID: 84883257978     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12251     Document Type: Article

References (37)

1. Adams DJ, Smith AB, Schroeder CI, Yasuda T, Lewis RJ, (2003). Omega-conotoxin CVID inhibits a pharmacologically distinct voltage-sensitive calcium channel associated with transmitter release from preganglionic nerve terminals. J Biol Chem 278: 4057-4062.
2. Adams DJ, Callaghan B, Berecki G, (2012). Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type (Ca(V) 2.2) calcium channels. Br J Pharmacol 166: 486-500.
3. Alexander SPH, Mathie A, Peters JA, (2011). Guide to receptors and channels (GRAC), 5th edition. Br J Pharmacol 164 (Suppl. 1): S1-S324.
4. Berecki G, Motin L, Haythornthwaite A, Vink S, Bansal P, Drinkwater R, et al. (2010). Analgesic (omega)-conotoxins CVIE and CVIF selectively and voltage-dependently block recombinant and native N-type calcium channels. Mol Pharmacol 77: 139-148.
5. Berry MS, Pentreath VW, (1976). Criteria for distinguishing between monosynaptic and polysynaptic transmission. Brain Res 105: 1-20.
6. Blake DW, Scott DA, Angus JA, Wright CE, (2005). Synergy between intrathecal omega-conotoxin CVID and dexmedetomidine to attenuate mechanical hypersensitivity in the rat. Eur J Pharmacol 506: 221-227.
7. Boroujerdi A, Kim HK, Lyu YS, Kim DS, Figueroa KW, Chung JM, et al. (2008). Injury discharges regulate calcium channel alpha-2-delta-1 subunit upregulation in the dorsal horn that contributes to initiation of neuropathic pain. Pain 139: 358-366.
8. Bowersox SS, Gadbois T, Singh T, Pettus M, Wang YX, Luther RR, (1996). Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. J Pharmacol Exp Ther 279: 1243-1249.
9. Chaplan SR, Pogrel JW, Yaksh TL, (1994). Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J Pharmacol Exp Ther 269: 1117-1123.
10. Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpaa ML, et al. (2010). Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 85: S3-S14.
11. Ekberg J, Jayamanne A, Vaughan CW, Aslan S, Thomas L, Mould J, et al. (2006). muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. Proc Natl Acad Sci U S A 103: 17030-17035.
12. Hama A, Sagen J, (2009). Antinociceptive effects of the marine snail peptides conantokin-G and conotoxin MVIIA alone and in combination in rat models of pain. Neuropharmacology 56: 556-563.
13. Heinke B, Balzer E, Sandkuhler J, (2004). Pre- and postsynaptic contributions of voltage-dependent Ca2+ channels to nociceptive transmission in rat spinal lamina I neurons. Eur J Neurosci 19: 103-111.
14. Iwasaki S, Momiyama A, Uchitel OD, Takahashi T, (2000). Developmental changes in calcium channel types mediating central synaptic transmission. J Neurosci 20: 59-65.
15. Jensen TS, Baron R, Haanpaa M, Kalso E, Loeser JD, Rice AS, et al. (2011). A new definition of neuropathic pain. Pain 152: 2204-2205.
16. Jeong HJ, Vandenberg RJ, Vaughan CW, (2010). N-arachidonyl-glycine modulates synaptic transmission in superficial dorsal horn. Br J Pharmacol 161: 925-935.
17. Lewis RJ, Nielsen KJ, Craik DJ, Loughnan ML, Adams DA, Sharpe IA, et al. (2000). Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes. J Biol Chem 275: 35335-35344.
18. Lewis RJ, Dutertre S, Vetter I, Christie MJ, (2012). Conus venom peptide pharmacology. Pharmacol Rev 64: 259-298.
19. Li CY, Song YH, Higuera ES, Luo ZD, (2004). Spinal dorsal horn calcium channel alpha2delta-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodynia. J Neurosci 24: 8494-8499.
20. McGivern JG, (2006). Targeting N-type and T-type calcium channels for the treatment of pain. Drug Discov Today 11: 245-253.
21. Malmberg AB, Yaksh TL, (1995). Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats. Pain 60: 83-90.
22. Morimoto S, Ito M, Oda S, Sugiyama A, Kuroda M, Adachi-Akahane S, (2012). Spinal mechanism underlying the antiallodynic effect of gabapentin studied in the mouse spinal nerve ligation model. J Pharmacol Sci 118: 455-466.
23. Motin L, Adams DJ, (2008). omega-Conotoxin inhibition of excitatory synaptic transmission evoked by dorsal root stimulation in rat superficial dorsal horn. Neuropharmacology 55: 860-864.
24. Motin L, Yasuda T, Schroeder CI, Lewis RJ, Adams DJ, (2007). Omega-conotoxin CVIB differentially inhibits native and recombinant N- and P/Q-type calcium channels. Eur J Neurosci 25: 435-444.
25. Mould J, Yasuda T, Schroeder CI, Beedle AM, Doering CJ, Zamponi GW, et al. (2004). The alpha2delta auxiliary subunit reduces affinity of omega-conotoxins for recombinant N-type (Cav2.2) calcium channels. J Biol Chem 279: 34705-34714.
26. Murali SS, Napier IA, Rycroft BK, Christie MJ, (2012). Opioid-related (ORL1) receptors are enriched in a subpopulation of sensory neurons and prolonged activation produces no functional loss of surface N-type calcium channels. J Physiol (Lond) 590: 1655-1667.
27. Ogawa K, Takasu K, Shinohara S, Yoneda Y, Kato A, (2011). Pharmacological characterization of lysophosphatidic acid-induced pain with clinically relevant neuropathic pain drugs. Eur J Pain 16: 994-1004.
28. Rycroft BK, Vikman KS, Christie MJ, (2007). Inflammation reduces the contribution of N-type calcium channels to primary afferent synaptic transmission onto NK1 receptor-positive lamina I neurons in the rat dorsal horn. J Physiol (Lond) 580: 883-894.
29. Scott DA, Wright CE, Angus JA, (2002). Actions of intrathecal omega-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat. Eur J Pharmacol 451: 279-286.
30. Seltzer Z, Dubner R, Shir Y, (1990). A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43: 205-218.
31. Smith MT, Cabot PJ, Ross FB, Robertson AD, Lewis RJ, (2002). The novel N-type calcium channel blocker, AM336, produces potent dose-dependent antinociception after intrathecal dosing in rats and inhibits substance P release in rat spinal cord slices. Pain 96: 119-127.
32. Snutch TP, (2005). Targeting chronic and neuropathic pain: the N-type calcium channel comes of age. NeuroRx 2: 662-670.
33. Souza AH, Ferreira J, Cordeiro Mdo N, Vieira LB, De Castro CJ, Trevisan G, et al. (2008). Analgesic effect in rodents of native and recombinant Ph alpha 1beta toxin, a high-voltage-activated calcium channel blocker isolated from armed spider venom. Pain 140: 115-126.
34. Vuong LAQ, Mitchell VA, Vaughan CW, (2008). Actions of N-arachidonyl-glycine in a rat neuropathic pain model. Neuropharmacology 54: 189-193.
35. Westenbroek RE, Hell JW, Warner C, Dubel SJ, Snutch TP, Catterall WA, (1992). Biochemical properties and subcellular distribution of an N-type calcium channel alpha 1 subunit. Neuron 9: 1099-1115.
36. Wright CE, Robertson AD, Whorlow SL, Angus JA, (2000). Cardiovascular and autonomic effects of omega-conotoxins MVIIA and CVID in conscious rabbits and isolated tissue assays. Br J Pharmacol 131: 1325-1336.
37. Yamamoto T, Sakashita Y, (1998). Differential effects of intrathecally administered N- and P-type voltage-sensitive calcium channel blockers upon two models of experimental mononeuropathy in the rat. Brain Res 794: 329-332.